Publications by authors named "Zhiting Zhao"

Claim this Profile
R
Recent Applications of Disulfide Bond-Containing Compounds in Medicinal and Agrochemical Chemistry.
Sijia Liu, Peiyao Zhang, Zhiting Zhao, Mingpeng Li, Ziheng Jin

J Agric Food Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HHLA2 promotes immune evasion in EGFR-mutant lung cancer by inhibiting CD8 T cell glutamine metabolism via KIR3DL3 interaction.
Fei Wu, Jiannan Shen, Zhiting Zhao, Yan Chen, Binhui Ren

Cancer Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indole-based natural product for plant protection: Discovery of alkaloid barrettin and its derivatives as novel antiviral and antifungal agents.
Peiyao Zhang, Ziheng Jin, Zhiting Zhao, Jin Kang, Aidang Lu

Pestic Biochem Physiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, structural optimization, and biological activity research of quinazolinone alkaloid isaindigotone.
Sijia Liu, Yubin Xu, Mingpeng Li, Zhiting Zhao, Aidang Lu

Pest Manag Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis.
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Fei Wu, Ning Sun

Int J Clin Pract· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis.
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Xiao Hu, Jifeng Feng

Technol Cancer Res Treat· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study.
Zhiting Zhao, Luqing Zhao, Guohao Xia, Jianwei Lu, Bo Shen

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection.
Zhiting Zhao, Ran Hu, Yan Chen, Guoren Zhou, Shaorong Yu

Oncol Res Treat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy.
Ranpu Wu, Shaorong Yu, Jinjun Ye, Yimin Wang, Zhiting Zhao

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysis.
Ran Hu, Zhiting Zhao, Yue Shi, Meiqi Shi, Guohao Xia

J Thorac Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis